Plus   Neg

Xerox Mulling A Bid For HP: Report

Xerox Holdings Corp. (XRX) is said to be mulling over launching a takeover bid for PC and printer maker HP Inc. (HPQ), according to a Wall Street Journal report.

Xerox is considering a cash-and-stock offer for HP, which has a current market capitalization of about $27 billion, according to people familiar with the matter.

The copier maker's board is said to have discussed the possibility Tuesday, the people said. HP is more than three times the size of Xerox and any bid would be at a premium to its current stock price.

Xerox has also reportedly received an informal funding commitment from a major bank," the people said. Further, it is also expecting a $2.3 billion windfall from a deal announced on Tuesday to sell stakes in joint ventures with Fujifilm Holdings Corp.

Xerox primarily makes large printers and copy machines, with most of its revenues coming from renting and maintaining them for businesses. Meanwhile, HP sells mainly smaller printers and printing supplies and is also one of the largest PC makers in the world.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Global PC shipments returned to growth in the second quarter of 2020 after seeing a significant decline in the preceding first quarter due to COVID-19 related supply-chain disruptions, according to reports by two research firms. The PC market returned to growth in the quarter as production ramped up and vendors restocked their supplies to near-normal levels. The bankruptcy filing of America's oldest apparel retailer Brooks Brothers has ignited significant interest from potential buyers for the brand. WHP Global and a venture backed by Authentic Brands Group LLC and Simon Property Group, Inc., are reportedly considering bids for the retailer. WHP Global owns the ANNE KLEIN and JOSEPH ABBOUD brands. Sundial Herbal Products has recalled around 65 products, which were misbranded and currently unapproved drugs, the U.S. Food and Drug Administration said in a statement. The recall follows an order by a federal judge in June to stop distributing the company's unapproved new drugs. The affected items include herbal products and dietary supplements.
Follow RTT